Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes

Antiangiogenics administration in colorectal cancer patients seemed promising therapeutic approach. Inspite of early encouraging results, it however gave only modest clinical benefits. When AAG was administered with discontinuous schedule, the disease showed acceleration in certain cases. Though res...

Descripción completa

Detalles Bibliográficos
Autores principales: Becherirat, Selma, Valamanesh, Fatemeh, Karimi, Mojgan, Faussat, Anne-Marie, Launay, Jean-Marie, Pimpie, Cynthia, Therwath, Amu, Pocard, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832744/
https://www.ncbi.nlm.nih.gov/pubmed/29459325
http://dx.doi.org/10.1016/j.tranon.2018.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832744/
https://www.ncbi.nlm.nih.gov/pubmed/29459325
http://dx.doi.org/10.1016/j.tranon.2018.01.017

Ejemplares similares